{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:18:43Z","timestamp":1771373923596,"version":"3.50.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR000003"],"award-info":[{"award-number":["UL1TR000003"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Fluorine Chemistry"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.jfluchem.2014.09.019","type":"journal-article","created":{"date-parts":[[2014,9,28]],"date-time":"2014-09-28T17:17:54Z","timestamp":1411924674000},"page":"121-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Synthesis and anticancer activity evaluation of 3,4-mono- and bicyclosubstituted N-(het)aryl trifluoromethyl succinimides"],"prefix":"10.1016","volume":"168","author":[{"given":"Elena L.","family":"Luzina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatoliy V.","family":"Popov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfluchem.2014.09.019_bib0005","series-title":"Fluorine in Bioorganic Chemistry","author":"Welch","year":"1991"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0010","series-title":"Organofluorine Compounds in Medicinal Chemistry and Biomedical Applications","year":"1993"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0015","series-title":"Organofluorine Compounds: Chemistry and Applications","author":"Hiyama","year":"2001"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0020","series-title":"Applications","article-title":"Modern Fluoroorganic Chemistry: Synthesis, Reactivity","author":"Kirsch","year":"2004"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0025","series-title":"Molecular Medicine and Medicinal Chemistry","doi-asserted-by":"crossref","first-page":"p572","DOI":"10.1142\/p746","author":"Gouverneur","year":"2012"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0030","series-title":"Fluorine in Medicinal Chemistry and Chemical Biology","first-page":"640","author":"Ojima","year":"2009"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0035","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1021\/cr4002879","article-title":"Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001-2011)","volume":"114","author":"Wang","year":"2014","journal-title":"Chem. Rev. (Washington, DC U.S.)"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jfluchem.2014.06.026","article-title":"Recent advances in the trifluoromethylation methodology and new CF3-containing drugs","author":"Zhu","year":"2014","journal-title":"J Fluorine Chem"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0045","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1126\/science.1131943","article-title":"Fluorine in Pharmaceuticals: Looking Beyond Intuition","volume":"317","author":"Mueller","year":"2007","journal-title":"Science (Washington, DC, U.S.)"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0050","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1039\/B610213C","article-title":"Fluorine in medicinal chemistry","volume":"37","author":"Purser","year":"2008","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0055","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1021\/jm800219f","article-title":"The Many Roles for Fluorine in Medicinal Chemistry","volume":"51","author":"Hagmann","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0060","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1016\/S0040-4039(00)88357-4","article-title":"New and direct route to 5-trifluoromethyl-5, 6-dihydrouracils by palladium complex-catalyzed \u201cureidocarbonylation\u201d of 2-bromo-3,3,3-trifluoropropene","volume":"23","author":"Fuchikami","year":"1982","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0065","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-1139(00)80396-6","article-title":"Facile perfluoroalkylation of uracils and uridines at the C-5 position","volume":"63","author":"Nishida","year":"1993","journal-title":"J. Fluorine Chem."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0070","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0022-1139(95)03386-6","article-title":"A new synthesis of 5-trifluoromethyluracil","volume":"77","author":"Andres","year":"1996","journal-title":"J. Fluorine Chem."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0075","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1007\/BF02503508","article-title":"Polyfluorinated enamines","volume":"47","author":"Popov","year":"1998","journal-title":"New methods for the synthesis of 5-trifluoromethyluracil, Russ. Chem. Bull."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0080","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000221929","article-title":"Growth inhibition of cells in culture and of vaccinia virus infected HeLa cells by derivatives of trifluorothymidine","volume":"22","author":"Parkhurst","year":"1976","journal-title":"Chemotherapy (Basel)"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0085","first-page":"58","article-title":"Fluorinated pyrimidines and their nucleosides","volume":"54","author":"Heidelberger","year":"1983","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0090","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF00689963","article-title":"Potentiation of the antitumor activity of 5-trifluoromethyl-2\u2019-deoxyuridine by the use of depot forms of the parent compound","volume":"30","author":"Takeda","year":"1992","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0095","doi-asserted-by":"crossref","first-page":"7156","DOI":"10.1021\/jm100803c","volume":"53","author":"Srivastav","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0100","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.ejmech.2011.01.005","article-title":"Synthesis and biological evaluation of unsaturated keto and exomethylene D-arabinopyranonucleoside analogs: Novel 5-fluorouracil analogs that target thymidylate synthase","volume":"46","author":"Tzioumaki","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0105","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1016\/j.ejmech.2009.08.007","article-title":"Synthesis and anticancer activity of N-bis(trifluoromethyl)alkyl-N\u2019-thiazolyl and N-bis(trifluoromethyl)alkyl-N\u2019-benzothiazolyl ureas","volume":"44","author":"Luzina","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0110","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1016\/j.ejmech.2010.08.057","article-title":"Anticancer activity of N-bis(trifluoromethyl)alkyl-N\u2019-(polychlorophenyl) and N\u2019-(1,2,4-triazolyl) ureas","volume":"45","author":"Luzina","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0115","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejmech.2012.03.026","article-title":"Synthesis, evaluation of anticancer activity and COMPARE analysis of N-bis(trifluoromethyl)alkyl-N\u2019-substituted ureas with pharmacophoric moieties","volume":"53","author":"Luzina","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jfluchem.2013.01.033","article-title":"Synthesis of 1-aroyl(1-arylsulfonyl)-4-bis(trifluoromethyl)alkyl semicarbazides as potential physiologically active compounds","volume":"148","author":"Luzina","year":"2013","journal-title":"J. Fluorine Chem."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0125","unstructured":"A.N. Chekhlov, A.V. Popov, E.L. Luzina, A.N. Pushin, I.V. Martynov, Crystal and molecular structure and synthesis of N-(4-methoxyphenyl)-2-exo-(trifluoromethyl)-5-norbornene-cis-endo-2,3-dicarboximide, Dokl. Chem. 331 (1993) 168-172 (Engl. Transl.) 339 (1994) 65-69.[Dokl. Chem. 339(1994) 1208-1212 (Engl. Transl.)]."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0130","unstructured":"A.N. Chekhlov, A.V. Popov, A.N. Pushin, Crystal and molecular structure and synthesis of (E)-N,N-dimethyl-2-trifluoromethyl-3-(3,3,3-trifluoro-2-trifluoromethylprop-1-enyloxy)acrylamide, Dokl. Chem. 331 (1993) 168-172 (Engl. Transl.) 331 (1993) 62-65 [Dokl. Chem. 331(1993) 1168-1172 (Engl. Transl.)]."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0135","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/BF01434004","article-title":"Polyfluorinated enamines. Synthesis of N-[(3,3,3-trifluoro-2-(trifluoromethyl)prop-1-enyl]urea","volume":"45","author":"Popov","year":"1996","journal-title":"Russ. Chem. Bull."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0140","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1007\/BF02496143","article-title":"Reaction of N-(3,3,3-trifluoro-2-trifluoromethylprop-1-enyl)dimethylamine with MgSO4.7H2O. Synthesis of 4,4-difluoro-5-trifluoromethyl-2-(2,2,2-trifluoro-1-trifluoromethylethyl)-4H-1,3-dioxin and cis\/trans-3-dimethylamino-2-trifluoromethacryloyl fluoride","volume":"46","author":"Popov","year":"1997","journal-title":"Russ. Chem. Bull."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0145","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/BF02495761","article-title":"Synthesis of 1 1-bis(trifluoromethyl)alkyl isocyanates, carbamates, and ureas","volume":"49","author":"Popov","year":"2000","journal-title":"Russ. Chem. Bull."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0150","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1007\/BF02496410","article-title":"Synthesis of substituted 2-amino-4,6-bis(nonafluoro-tert-butyl)-1,3,5-triazines","volume":"48","author":"Popov","year":"1999","journal-title":"Russ. Chem. Bull."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0155","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/jm00213a018","article-title":"Potential long-acting anticonvulsants. 1. Synthesis and activity of succinimides containing an alkylating group at the 2 position","volume":"20","author":"Kornet","year":"1977","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0160","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1021\/jm00219a020","article-title":"Potential long-acting anticonvulsants. 2. Synthesis and activity of succinimides containing an alkylating group on nitrogen or at the 3 position","volume":"20","author":"Kornet","year":"1977","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0165","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1021\/jm00364a020","article-title":"Synthesis of aminomethyl-substituted cyclic imide derivatives for evaluation as anticonvulsants","volume":"26","author":"Stratford","year":"1983","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0170","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1021\/jm00158a026","article-title":"Buspirone analogs. 2. Structure-activity relationships of aromatic imide derivatives","volume":"29","author":"New","year":"1986","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0175","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1124\/mol.60.5.1121","article-title":"Block of cloned human T-type calcium channels by succinimide antiepileptic drugs","volume":"60","author":"Gomora","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0180","first-page":"19","article-title":"Effects of N-substituted phthalimide, saccharin, succinimide, and indandione derivatives on the type I and II isoforms of human Tmolt4 T cell IMP dehydrogenase","volume":"6","author":"Hall","year":"2001","journal-title":"Res. Commun. Pharmacol. Toxicol."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0185","first-page":"2053","article-title":"Cytotoxicity and mode of action of substituted indan-1,3-diones in murine and human tissue cultured cells","volume":"14","author":"Hall","year":"1994","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0190","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1016\/j.ejmech.2010.05.053","article-title":"Therapeutic effects of cantharidin analogues without bridging ether oxygen on human hepatocellular carcinoma cells","volume":"45","author":"Yeh","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0195","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/cbdd.12180","article-title":"Cantharidin-based small molecules as potential therapeutic agents","volume":"82","author":"Puerto Galvis","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0200","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jecm.2012.09.004","article-title":"Synthesis and Evaluation of Cantharidinimides on Human Cancer Cells","volume":"4","author":"Tseng","year":"2012","journal-title":"J Exp Clin Med"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0205","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.bbrc.2014.04.035","article-title":"A novel cantharidin analog N-Benzylcantharidinamide reduces the expression of MMP-9 and invasive potentials of Hep3B via inhibiting cytosolic translocation of HuR","volume":"447","author":"Lee","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0210","unstructured":"V.A. Soloshonok, Y.L. Yagupol'skii, V.P. Kukhar, Derivatives of \u03b1-(trifluoromethyl)malic acid and their reactions, Zh. Org. Khim. 25 (1989) 2523-2527.[J. Org. Chem. USSR 2525 (1989) 2263-2266 (Engl. Transl.)]."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0215","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0022-1139(00)81523-7","article-title":"Trifluoromethylmaleic anhydride","volume":"21","author":"England","year":"1982","journal-title":"J. Fluorine Chem."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0220","series-title":"Syntheses of Fluoroorganic Compounds","year":"1985"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0225","doi-asserted-by":"crossref","first-page":"39","DOI":"10.15227\/orgsyn.022.0039","article-title":"2,3-Dimethyl-1,3-butadiene. I. Hydrobromic acid method","volume":"22","author":"Allen","year":"1942","journal-title":"Org. Synth"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0230","doi-asserted-by":"crossref","first-page":"41","DOI":"10.15227\/orgsyn.032.0041","article-title":"Cyclopentadiene and 3-chlorocyclopentene","volume":"32","author":"Moffett","year":"1952","journal-title":"Org. Synth."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0235","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0245","unstructured":"J.G. Gelovani, in: 2011 World Molecuilar Imaging Congress, San Diego, CA, USA, September, 7-10, 2011, pp. 19."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0250","unstructured":"Available from: http:\/\/www.pharmaexpert.ru\/PASSOnline\/index.php."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0255","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s10593-014-1496-1","article-title":"Prediction of the Biological Activity Spectra of Organic Compounds Using the Pass Online Web Resource","volume":"50","author":"Filimonov","year":"2014","journal-title":"Chem. Heterocycl. Compd. (N. Y., NY, U.S.)"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0260","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/bioinformatics\/16.8.747","article-title":"PASS: prediction of activity spectra for biologically active substances","volume":"16","author":"Lagunin","year":"2000","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0265","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/10629360310001623935","article-title":"Prediction of biological activity spectra via the Internet","volume":"14","author":"Sadym","year":"2003","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0270","unstructured":"Available from: http:\/\/59.78.96.61\/pharmmapper."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0275","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ddtec.2006.12.008","article-title":"In silico target fishing: Predicting biological targets from chemical structure","volume":"3","author":"Jenkins","year":"2006","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0280","doi-asserted-by":"crossref","unstructured":"X. Liu, S. Ouyang, B. Yu, Y. Liu, K. Huang, J. Gong, S. Zheng, Z. Li, H. Li, H. Jiang, PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach, Nucleic Acids Res. 38 (2010) W609-W614.","DOI":"10.1093\/nar\/gkq300"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0285","unstructured":"Available from: http:\/\/dtp.nci.nih.gov\/branches\/btb\/onedose_interp.html."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0290","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/jnci\/81.14.1088","article-title":"Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm","volume":"81","author":"Paull","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0295","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1093-3263(01)00126-7","article-title":"COMPARE: a web accessible tool for investigating mechanisms of cell growth inhibition","volume":"20","author":"Zaharevitz","year":"2002","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0300","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/10629360701843649","article-title":"Computer-aided prediction for medicinal chemistry via the Internet","volume":"19","author":"Geronikaki","year":"2008","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0305","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1021\/jm021089h","article-title":"Computer-Aided Selection of Potential Antihypertensive Compounds with Dual Mechanism of Action","volume":"46","author":"Lagunin","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0310","first-page":"589","article-title":"Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay","volume":"48","author":"Alley","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0315","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ddr.430340203","article-title":"Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen","volume":"34","author":"Boyd","year":"1995","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0320","first-page":"622","article-title":"The National Cancer Institute: cancer drug discovery and development program","volume":"19","author":"Grever","year":"1992","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0325","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrc1951","article-title":"The NCI60 human tumour cell line anticancer drug screen","volume":"6","author":"Shoemaker","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jfluchem.2014.09.019_bib0330","unstructured":"Available from: http:\/\/dtp.nci.nih.gov\/docs\/cancer\/searches\/standard_agent_table.html."}],"container-title":["Journal of Fluorine Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022113914002838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022113914002838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T13:39:48Z","timestamp":1758289188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022113914002838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":66,"alternative-id":["S0022113914002838"],"URL":"https:\/\/doi.org\/10.1016\/j.jfluchem.2014.09.019","relation":{},"ISSN":["0022-1139"],"issn-type":[{"value":"0022-1139","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and anticancer activity evaluation of 3,4-mono- and bicyclosubstituted N-(het)aryl trifluoromethyl succinimides","name":"articletitle","label":"Article Title"},{"value":"Journal of Fluorine Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfluchem.2014.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}